The Angiotensin AT2 Receptor: From Enigma to Therapeutic Target

The Protective Arm of the Renin Angiotensin System (RAS): Functional Aspects and Therapeutic Implications

Volumn , Issue , 2015, Pages 1-9

  Unger, Thomas ^a   Steckelings, Ulrike M ^b   Dzau, Victor J ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c NATIONAL ACADEMIES OF SCIENCES   (United States)

Author keywords

Angiotensin AT2 receptor; AT2R features; AT2R functions; AT2R research history; Neuroprotection; Renin angiotensin system

Indexed keywords

EID: 84937541326     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-801364-9.00001-8     Document Type: Chapter

References (99)

1. Unger T. The angiotensin type 2 receptor: variations on an enigmatic theme. J Hypertens 1999, 17:1775-1786.
2. Horiuchi M., Akishita M., Dzau V.J. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999, 33:613-621.
3. Gallinat S., Busche S., Raizada M.K., Sumners C. The angiotensin II type 2 receptor: an enigma with multiple variations. Am J Physiol Endocrinol Metab 2000, 278:E357-E374.
4. Whitebread S., Mele M., Kamber B., de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989, 163:284-291.
5. De Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000, 52:415-472.
6. Mukoyama M., Nakajima M., Horiuchi M., Sasamura H., Pratt R.E., Dzau V.J. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993, 268:24539-24542.
7. Nakajima M., Mukoyama M., Pratt R.E., Horiuchi M., Dzau V.J. Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor. Biochem Biophys Res Commun 1993, 197:393-399.
8. Kambayashi Y., Bardhan S., Takahashi K., Tsuzuki S., Inui H., Hamakubo T., et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993, 268:24543-24546.
9. Tsuzuki S., Ichiki T., Nakakubo H., Kitami Y., Guo D.F., Shirai H., et al. Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor. Biochem Biophys Res Commun 1994, 200:1449-1454.
10. Ichiki T., Herold C.L., Kambayashi Y., Bardhan S., Inagami T. Cloning of the cDNA and the genomic DNA of the mouse angiotensin II type 2 receptor. Biochim Biophys Acta 1994, 1189:247-250.
11. Koike G., Horiuchi M., Yamada T., Szpirer C., Jacob H.J., Dzau V.J. Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung. Biochem Biophys Res Commun 1994, 203:1842-1850.
12. Katsuya T., Horiuchi M., Minami S., Koike G., Santoro N.F., Hsueh A.J., et al. Genomic organization and polymorphism of human angiotensin II type receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome. Mol Cell Endocrinol 1997, 127(2):221-228.
13. Hein L., Barsh G.S., Pratt R.E., Dzau V.J., Kobilka B.K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995, 377:744-747.
14. Ichiki T., Labosky P.A., Shiota C., Okuyama S., Imagawa Y., Fogo A., et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995, 377:748-750.
15. Unger T., Mattfeldt T., Lamberty V., Bock P., Mall G., Linz W., et al. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 1992, 20:478-482.
16. Metsärinne K.P., Stoll M., Gohlke P., Paul M., Unger T. Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharm Pharmacol Lett 1992, 2:150-152.
17. Bottari S.P., King I.N., Reichlin S., Dahlstroem I., Lydon N., de Gasparo M. The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem Biophys Res Commun 1992, 183:206-211.
18. Schelling P., Ganten D., Speck G., Fischer H. Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells. J Cell Physiol 1979, 98:503-513.
19. Nakajima M., Hutchinson H.G., Fujinaga M., Hayashida W., Morishita R., Zhang L., et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A 1995, 92:10663-10667.
20. Stoll M., Steckelings U.M., Paul M., Bottari S.P., Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995, 95:651-657.
21. Horiuchi M., Koike G., Yamada T., Mukoyama M., Nakajima M., Dzau V.J. The growth-dependent expression of angiotensin II type 2 receptor is regulated by transcription factors interferon regulatory factor-1 and 2. J Biol Chem 1995, 270:20225-20230.
22. Horiuchi M., Iwanami J., Mogi M. Regulation of angiotensin II receptors beyond the classical pathway. Clin Sci Lond Eng 1979 2012, 123:193-203.
23. Csikós T., Chung O., Unger T. Receptors and their classification: focus on angiotensin II and the AT2 receptor. J Hum Hypertens 1998, 12:311-318.
24. Volpe M., Musumeci B., De Paolis P., Savoia C., Morganti A. Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease?. J Hypertens 2003, 21:1429-1443.
25. Utsunomiya H., Nakamura M., Kakudo K., Inagami T., Tamura M. Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice. Regul Pept 2005, 126:155-161.
26. Steckelings U.M., Kaschina E., Unger T. The AT2 receptor-a matter of love and hate. Peptides 2005, 26:1401-1409.
27. Padia S.H., Carey R.M. AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pflüg Arch Eur J Physiol 2013, 465:99-110.
28. Hayashida W., Horiuchi M., Dzau V.J. Intracellular third loop domain of angiotensin II type-2 receptor: role in mediating signal transduction and cellular function. J Biol Chem 1996, 271:21985-21992.
29. Kang J., Posner P., Sumners C. Angiotensin II type 2 receptor stimulation of neuronal K+ currents involves an inhibitory GTP binding protein. Am J Physiol 1994, 267:C1389-C1397.
30. Zhang J., Pratt R.E. The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus. J Biol Chem 1996, 271:15026-15033.
31. Funke-Kaiser H., Reinemund J., Steckelings U.M., Unger T. Adapter proteins and promoter regulation of the angiotensin AT2 receptor-implications for cardiac pathophysiology. J Renin-Angiotensin-Aldosterone Syst 2010, 11:7-17.
32. Mukoyama M., Horiuchi M., Nakajima M., Pratt R.E., Dzau V.J. Characterization of rat type 2 angiotensin II receptor stably expressed in 293 cells. Mol Cell Endocrinol 1995, 112:61-68.
33. Hein L., Meinel L., Pratt R.E., Dzau V.J., Kobilka B.K. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 1997, 11:1266-1277.
34. Csikós T., Balmforth A.J., Grojec M., Gohlke P., Culman J., Unger T. Angiotensin AT2 receptor degradation is prevented by ligand occupation. Biochem Biophys Res Commun 1998, 243:142-147.
35. Miura S.-I., Karnik S.S., Saku K. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J Biol Chem 2005, 280:18237-18244.
36. AbdAlla S., Lother H., Abdel-tawab A.M., Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001, 276:39721-39726.
37. Abadir P.M., Periasamy A., Carey R.M., Siragy H.M. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension 2006, 48:316-322.
38. Villela D.C., Munter L.-M., Multhaup G., Mayer M., Benz V., Namsolleck P., et al. Evidence of a direct MAS-AT2 receptor dimerization. J Hypertens 2012, 30:e117.
39. Feng Y.-H., Sun Y., Douglas J.G. Gbeta gamma-independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1. Proc Natl Acad Sci U S A 2002, 99:12049-12054.
40. Nouet S., Amzallag N., Li J.-M., Louis S., Seitz I., Cui T.-X., et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 2004, 279:28989-28997.
41. Wruck C.J., Funke-Kaiser H., Pufe T., Kusserow H., Menk M., Schefe J.H., et al. Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 2005, 25:57-64.
42. Rodrigues-Ferreira S., Nahmias C. An ATIPical family of angiotensin II AT2 receptor-interacting proteins. Trends Endocrinol Metab 2010, 21:684-690.
43. Senbonmatsu T., Saito T., Landon E.J., Watanabe O., Price E., Roberts R.L., et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 2003, 22:6471-6482.
44. Schefe J.H., Menk M., Reinemund J., Effertz K., Hobbs R.M., Pandolfi P.P., et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 2006, 99:1355-1366.
45. Horiuchi M., Hayashida W., Akishita M., Tamura K., Daviet L., Lehtonen J.Y., et al. Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk. Circ Res 1999, 84:876-882.
46. Akishita M., Horiuchi M., Yamada H., Zhang L., Shirakami G., Tamura K., et al. Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol Genomics 2000, 2(1):13-20.
47. Rompe F., Artuc M., Hallberg A., Alterman M., Ströder K., Thöne-Reineke C., et al. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappa B. Hypertension 2010, 55:924-931.
48. Yamada H., Akishita M., Ito M., Tamura K., Daviet L., Lehtonen J.Y., et al. AT2 receptor and vascular smooth muscle cell differentiation in vascular development. Hypertension 1999, 33(6):1414-1419.
49. Ohkubo N., Matsubara H., Nozawa Y., Mori Y., Murasawa S., Kijima K., et al. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 1997, 96(11):3954-3962.
50. Lucius R., Gallinat S., Rosenstiel P., Herdegen T., Sievers J., Unger T. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 1998, 188(4):661-670.
51. Reinecke K., Lucius R., Reinecke A., Rickert U., Herdegen T., Unger T. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J 2003, 17(14):2094-2096. Epub 2003 Sep 18.
52. Kemp B.A., Howell N.L., Gildea J.J., Keller S.R., Padia S.H., Carey R.M. AT2 receptor activation induces natriuresis and lowers blood pressure. Circ Res 2014, 115(3):388-399. Jun 5. pii: CIRC RESAHA.114.304110. [Epub ahead of print].
53. Yamada T., Horiuchi M., Dzau V.J. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A 1996, 93:156-160.
54. Horiuchi M., Hayashida W., Kambe T., Yamada T., Dzau V.J. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 1997, 272:19022-19026.
55. Horiuchi M., Yamada T., Hayashida W., Dzau V.J. Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis. J Biol Chem 1997, 272(18):11952-11958.
56. Yamada T., Akishita M., Pollman M., Gibbons G.H., Dzau V.J., Horiuchi M. Angiotensin II type 2 receptor mediates vascular muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci 1998, 63(19):289-295.
57. Lehtonen J.Y., Horiuchi M., Daviet L., Akishita M., Dzau V.J. Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. J Biol Chem 1999, 274(24):16901-16906.
58. Gallinat S., Busche S., Schütze S., Krönke M., Unger T. AT2 receptor stimulation induces generation of ceramides in PC12W cells. FEBS Lett 1999, 443(1):75-79.
59. Sumners C., Gelband C.H. Neuronal ion channel signalling pathways: modulation by angiotensin II. Cell Signal 1998, 10:303-311.
60. Carey R.M. Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension 2005, 45:840-844.
61. Namsolleck P., Recarti C., Foulquier S., Steckelings U.M., Unger T. AT(2) receptor and tissue injury: therapeutic implications. Curr Hypertens Rep 2014, 16:416.
62. Danyel L.A., Schmerler P., Paulis L., Unger T., Steckelings U.M. Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure. Integr Blood Press Control 2013, 6:153-161.
63. D'Amore A., Black M.J., Thomas W.G. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 2005, 46:1347-1354.
64. Levy B.I., Benessiano J., Henrion D., Caputo L., Heymes C., Duriez M., et al. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996, 98:418-425.
65. Senbonmatsu T., Ichihara S., Price E., Gaffney F.A., Inagami T. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000, 106:R25-R29.
66. Mifune M., Sasamura H., Shimizu-Hirota R., Miyazaki H., Saruta T. Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells. Hypertension 2000, 36:845-850.
67. Ichihara S., Senbonmatsu T., Price E., Ichiki T., Gaffney F.A., Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001, 104:346-351.
68. Masaki H., Kurihara T., Yamaki A., Norio I., Nozawa Y., Mori Y., et al. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest 1998, 101(3):527-535.
69. Steckelings U.M., Widdop R.E., Paulis L., Unger T. The angiotensin AT2 receptor in left ventricular hypertrophy. J Hypertens 2010, 28:S50-S55.
70. Akishita M., Ito M., Lehtonen J.Y., Daviet L., Dzau V.J., Horiuchi M. Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J Clin Invest 1999, 103(1):63-71.
71. Gallinat S., Yu M., Dorst A., Unger T., Herdegen T. Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves. Brain Res Mol Brain Res 1998, 57:111-122.
72. Li J., Culman J., Hörtnagl H., Zhao Y., Gerova N., Timm M., et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. J Off Publ Fed Am Soc Exp Biol 2005, 19:617-619.
73. Sales V.L., Sukhova G.K., Lopez-Ilasaca M.A., Libby P., Dzau V.J., Pratt R.E. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 2005, 112:3328-3336.
74. Dzau V.J., Mukoyama M., Pratt R.E. Molecular biology of angiotensin receptors: target for drug research?. J Hypertens 1994, 12(2):S1-S5.
75. Gohlke P., Pees C., Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998, 31:349-355.
76. Pees C., Unger T., Gohlke P. Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats. Int J Biochem Cell Biol 2003, 35:963-972.
77. Thai H., Wollmuth J., Goldman S., Gaballa M. Angiotensin subtype 1 receptor (AT1) blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor. J Pharmacol Exp Ther 2003, 307:1171-1178.
78. Barker T.A., Massett M.P., Korshunov V.A., Mohan A.M., Kennedy A.J., Berk B.C. Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade. Hypertension 2006, 48:942-949.
79. Jones E.S., Vinh A., McCarthy C.A., Gaspari T.A., Widdop R.E. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 2008, 120:292-316.
80. Danckwardt L., Shimizu I., Bönner G., Rettig R., Unger T. Converting enzyme inhibition in kinin-deficient brown Norway rats. Hypertension 1990, 16:429-435.
81. Linz W., Wiemer G., Gohlke P., Unger T., Schölkens B.A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995, 47:25-49.
82. Yayama K., Okamoto H. Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide. Int Immunopharmacol 2008, 8:312-318.
83. Zhao Y., Biermann T., Luther C., Unger T., Culman J., Gohlke P. Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells. J Neurochem 2003, 85:759-767.
84. Steckelings U.M., Rompe F., Kaschina E., Namsolleck P., Grzesiak A., Funke-Kaiser H., et al. The past, present and future of angiotensin II type 2 receptor stimulation. J Renin-Angiotensin-Aldosterone Syst 2010, 11:67-73.
85. Guimond M.-O., Gallo-Payet N. How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?. Front Endocrinol 2012, 3:164.
86. Sumners C., Horiuchi M., Widdop R.E., McCarthy C., Unger T., Steckelings U.M. Protective arms of the renin-angiotensin-system in neurological disease. Clin Exp Pharmacol Physiol 2013, 40:580-588.
87. Jing F., Mogi M., Sakata A., Iwanami J., Tsukuda K., Ohshima K., et al. Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metab 2012, 32:248-255.
88. Laflamme L., Gasparo M., Gallo J.M., Payet M.D., Gallo-Payet N. Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J Biol Chem 1996, 271:22729-22735.
89. Buisson B., Laflamme L., Bottari S.P., de Gasparo M., Gallo-Payet N., Payet M.D. A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells. J Biol Chem 1995, 270:1670-1674.
90. Meffert S., Stoll M., Steckelings U.M., Bottari S.P., Unger T. The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol 1996, 122:59-67.
91. Tsutsumi K., Saavedra J.M. Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 1991, 261:R209-R216.
92. Höhle S., Spitznagel H., Rascher W., Culman J., Unger T. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist. Eur J Pharmacol 1995, 275:277-282.
93. Gao L., Zucker I.H. AT2 receptor signaling and sympathetic regulation. Curr Opin Pharmacol 2011, 11:124-130.
94. Rosenstiel P., Gallinat S., Arlt A., Unger T., Sievers J., Lucius R. Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?. CNS Drugs 2002, 16:145-153.
95. Unger T., Chung O., Csikos T., Culman J., Gallinat S., Gohlke P., et al. Angiotensin receptors. J Hypertens 1996, 14:S95-103.
96. Wan Y., Wallinder C., Plouffe B., Beaudry H., Mahalingam A.K., Wu X., et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 2004, 47:5995-6008.
97. Steckelings U.M., Larhed M., Hallberg A., Widdop R.E., Jones E.S., Wallinder C., et al. Non-peptide AT2-receptor agonists. Curr Opin Pharmacol 2011, 11:187-192.
98. Ohshima K., Mogi M., Jing F., Iwanami J., Tsukuda K., Min L.-J., et al. Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation. PLoS One 2012, 7:e48387.
99. Willyard C. As drug target reemerges, the question is to block or stimulate it. Nat Med 2014, 20:222.